Perelel Secures $27M for Women's Health Innovation
Slice of Healthcare Team
11/21/2025
Key highlights
- $27 million secured from Prelude Growth Partners
- Focus on clinically-proven supplements for women
- Company achieved profitability in just five years
- Expanding support across all hormonal stages
- Commitment to quality and trust in women's health
Source: PR Newswire
Notable Quotes
“ This moment validates what we've built over the past five years: a business that proves women trust and return to brands that invest in clinical rigor and medically backed solutions. ”
Victoria Thain Gioia, Co-Founder and CEO at Perelel
“ As a doctor-founded brand with a commitment to products backed by clinical rigor and robust research, we've built our reputation on a foundation of trust. ”
Alex Taylor, Co-Founder at Perelel
“ Perelel's doctor-founding coupled with its clinical validation and commitment to women's health research stands out in the category. ”
Neda Daneshzadeh, Co-Founder and Managing Partner at Prelude Growth
Why this matters
This significant funding boosts Perelel's ability to expand its innovative women's health products. As the women’s health space faces challenges from unproven brands, Perelel’s focus on clinical rigor offers consumers a trusted alternative, reinforcing the growing demand for evidence-based wellness solutions. This development is particularly significant for the healthcare sector.
Expert Insights
Share Your Expert Insights
Have relevant experience or professional perspective? Add your thoughtful insights to this article.
